{"schema_version":"secwatch.filing_event.v1","accession":"0001828318-23-000059","form_type":"8-K","ticker":"ENVX","cik":"0001828318","company_name":"Enovix Corp","filed_at":"2023-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.870579+00:00","generated_at":"2026-06-19T05:24:28.628697+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Enovix Q4 2022 revenue $1.1M, net loss $11.2M; guides 180K cells in 2023","bullets":["Q4 2022 revenue $1.1M (service); GAAP net loss $11.2M ($0.07/share); Non-GAAP net loss $29.2M ($0.19/share).","Shipped 4,442 cells in Q4, exceeding internal goal; volume-weighted yield 42.9% (Q3: 16.4%).","Revenue funnel Active Design/Design Win grew 58% sequentially to $669M from $423M.","Guides Q1 2023 production of 9,000 cells (double Q4); full-year 2023 target 180,000 wearable-size cells.","2023 capex guidance $120M; net cash $322.9M; new COO Ajay Marathe appointed."],"urls":{"canonical":"https://secwatch.observer/filing/0001828318-23-000059","json":"https://secwatch.observer/filing/0001828318-23-000059.json","markdown":"https://secwatch.observer/filing/0001828318-23-000059.md","text":"https://secwatch.observer/filing/0001828318-23-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828318/000182831823000059/0001828318-23-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828318/000182831823000059/envx-20230222.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T05:24:28.628697+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b3fc09ed46c3578b8456e910a34df6878d0b8a5","claim":"Enovix Corp reported financial results for fourth fiscal quarter and fiscal year ended January 1, 2023.","evidence_excerpt":"On February 22, 2023, Enovix Corporation released its financial results for the fourth fiscal quarter and fiscal year ended January 1, 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1828318/000182831823000059/0001828318-23-000059-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth fiscal quarter and fiscal year ended January 1, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}